AMSBIO has launched CancerSeq™ - a new range of genetically characterised FFPE tissue samples. CancerSeq™ samples are prepared from genomic DNA extracted from the FFPE tumour tissues and validated by Next Generation ...
The US FDA has approved Chembio Diagnostics' Dual Path Platform (DPP) point-of-care HIV 1/2 rapid test. The DPP HIV 1/2 assay is developed to detect HIV-1/2 antibodies in either oral fluid or blood samples, which will bind directly with ...
Tags: FDA, HIV, oral fluid, detection reagents